How do I buy Larimar Therapeutics, Inc. Common Stock (LRMR) stock?

Buying Larimar Therapeutics, Inc. Common Stock (LRMR) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "LRMR", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy LRMR by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if LRMR is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Larimar Therapeutics, Inc. Common Stock (LRMR) Stock

Q: What is the minimum investment for LRMR on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Larimar Therapeutics, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · LRMR

Trade LRMR

Key stats

Market cap: $283.60M
Price / Earnings ratio: -1.6x
EPS (TTM): -$1.39
Volume: Loading
52-week high: $6.42
52-week low: $1.92

Source: third-party data provider, as of November 13, 2026

Compare with LRMR

Technical indicators

RSI 14: 52.98
MACD 12/26/9: -0.07
EMA 9 of MACD: -0.15
MACD histogram: 0.08
SMA 50: $2.97; Price below SMA 50
EMA 50: $2.88; Price below EMA 50
SMA 200: $3.77; Price below SMA 200
EMA 200: $3.52; Price below EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 1 analyst rating

Strong Sell0

Sell0

Hold0

Buy1

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

0000

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

240M159M79M0

Revenue to Profit

2025

$0.0

Revenue

$0.0

Cost of revenue

$0.0

Gross profit

$0.0

Operating expenses

$-165.7M

Net income

Earnings

No data available

Source: third-party data provider

About Larimar Therapeutics, Inc. Common Stock

No description available.

SectorHealthcare

IndustryBiotechnology

Employees71

CEODr. Carole S. Ben-Maimon M.D.

IPO DateJun 19, 2014

HeadquartersBala Cynwyd, PA

Key Executives

Name	Title	Year Born
Dr. Carole S. Ben-Maimon M.D.	CEO, President & Director	1959
Mr. Michael Celano CPA	Secretary & CFO	1959
Dr. Gopi Shankar M.B.A., Ph.D.	Chief Development Officer	1971
Mr. John Berman	Vice President of Finance & Administration	—
Ms. Jennifer Spokes Johansson	Vice President of Legal & Compliance	—
Dr. Russell G. Clayton Sr., D.O.	Chief Medical Officer	1961
Mr. Francis Michael Conway CPA	VP & Controller	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-16.3	+18.2
2022	-9.8	-54.9	-2.4	-3.6	-34.7	-24.0	-16.7	+63.9	+24.0	+4.1	-1.2	+30.3
2023	+23.5	+16.5	-22.2	+4.0	-20.6	-18.1	+39.0	-8.6	+3.1	-22.5	+19.5	+28.5
2024	+13.3	+91.7	-33.1	-7.6	+8.8	-20.7	+1.8	-4.9	-5.3	+31.3	-18.2	-37.6
2025	-4.2	-14.6	-18.9	+32.5	-21.3	+30.8	+20.1	+5.2	-12.9	-6.3	-8.8	+7.3
2026	+2.0	+51.3	-14.0	-13.2	-11.7	-13.1	+19.0	-4.0	-18.8	-19.3	+15.2

Stocks in the same sector

Vertex Pharmaceuticals

ABEO

Abeona Therapeutics Inc.

FAQ

Buying Larimar Therapeutics, Inc. Common Stock (LRMR) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "LRMR", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy LRMR by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Larimar Therapeutics, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Larimar Therapeutics, Inc. Common Stock (LRMR) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track LRMR's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Larimar Therapeutics, Inc. Common Stock (LRMR) Stock

Key stats

Compare with LRMR

Recent news

3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead

3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead

Larimar (LRMR) Loses 22.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Larimar (LRMR) Loses 22.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

5 Small Drug Stocks Poised to Benefit From a Biotech Recovery

5 Small Drug Stocks Poised to Benefit From a Biotech Recovery

LRMR Stock Edges Up After Hours After Director Purchases Shares Worth About $167,000

LRMR Stock Edges Up After Hours After Director Purchases Shares Worth About $167,000

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead

3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead

Larimar (LRMR) Loses 22.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Larimar (LRMR) Loses 22.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

5 Small Drug Stocks Poised to Benefit From a Biotech Recovery

5 Small Drug Stocks Poised to Benefit From a Biotech Recovery

LRMR Stock Edges Up After Hours After Director Purchases Shares Worth About $167,000

LRMR Stock Edges Up After Hours After Director Purchases Shares Worth About $167,000

LRMR Shares Hold Steady As Wall Street Optimism Offsets Drug Safety Concerns

LRMR Shares Hold Steady As Wall Street Optimism Offsets Drug Safety Concerns

2 Breakout Stocks to Buy Immediately

2 Breakout Stocks to Buy Immediately

LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?

LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?

Larimar Prices $100M Stock Sale After Record Rally Fueled By FDA Breakthrough Tag For Protein Replacement Therapy

Larimar Prices $100M Stock Sale After Record Rally Fueled By FDA Breakthrough Tag For Protein Replacement Therapy

Why Did Larimar Therapeutics’ Stock Surge Over 30% Pre-Market Today?

Why Did Larimar Therapeutics’ Stock Surge Over 30% Pre-Market Today?

Best Momentum Stocks to Buy for October 7th

Best Momentum Stocks to Buy for October 7th

About Larimar Therapeutics, Inc. Common Stock

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade